AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FluMist maker announces plan to achieve $2 billion in revenues by 2009.
2004 APR 7 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that it expects to achieve $2 billion in total revenues by 2009, driven by investments in its pipeline and the continued growth of its currently marketed products.
MedImmune also announced results from two phase III studies showing the refrigerator-stable formulation of FluMist (Influenza Virus Vaccine Live, Intranasal) was statistically significantly more effective than the injectable influenza vaccine in preventing culture-confirmed influenza. These data reaffirmed MedImmune's commitment to developing and commercializing FluMist. If successful, MedImmune expects peak annual FluMist sales in excess of $500 million in the U.S. and approximately $800 million worldwide.
David M. Mott, MedImmune's president and chief executive officer, stated, "We are encouraged by the initial results from phase III clinical trials with the refrigerator-stable version of FluMist and excited by its potential to substantially improve public health. We are equally excited about the surge in productivity in the rest of our pipeline, which we expect will result in having four phase III programs underway in 2005 and the addition of three new clinical targets per year for the next 3 years. These R&D [research and development] investments over the next few years are expected to drive significant long-term revenue and earnings growth for our shareholders."
As the company implements its 5-year plan, MedImmune projects full-year 2004 earnings per share (EPS) to range from $0.50-0.60, as ...
- FluMist to be donated to public health agencies.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...doctors offices that distribute FluMist. He said the donation clears...the hope they will remember FluMist next flu season. Flu vaccines...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- FluMist maker reports record revenues and earnings for the first quarter.
- Newspaper article from: Vaccine Weekly May 19, 2004 700+ words
...down of the 2004/2005 FluMist seasonal inventory produced...including Vitaxin, Numax, FluMist, and CAIV-T. Selling...the costs for manufacturing FluMist prior to the vaccine's approval...This article was prepared by Vaccine Weekly editors from staff and other...
- FDA advisory committee recommends approval for FluMist.(Brief Article)
- Newspaper article from: Vaccine Weekly January 22, 2003 700+ words
...nose/nasal congestion. "FluMist is cutting-edge technology...Wyeth Pharmaceuticals. "FluMist, with its intranasal administration...15 billion. If and when FluMist is approved for marketing...This article was prepared by Vaccine Weekly editors from staff and other...
- Henry Schein named exclusive distributor of FluMist.
- Newspaper article from: Vaccine Weekly July 14, 2004 700+ words
...substantially reduced the price of FluMist to approximately one-half...season. Henry Schein will sell FluMist to physicians and pharmacies...healthcare providers include FluMist in their arsenal of flu...This article was prepared by Vaccine Weekly editors from staff and other...
- FluMist maker says costs hold profit growth to 1%.
- Newspaper article from: Vaccine Weekly May 12, 2004 700+ words
...contribution from its high-profile FluMist influenza vaccine until 2007...winter cold and flu season. FluMist generated first-quarter...the co-marketing deal for FluMist, which didn't produce the...This article was prepared by Vaccine Weekly editors from staff and other...
- North Carolina health plan to cover cost of FluMist.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...has provided coverage for FluMist as an in-network benefit...reimbursed. Typical charges for FluMist are between $60 and $70...vaccines. Under BCBSNC's new FluMist policy for this flu season...This article was prepared by Vaccine Weekly editors from staff and other...
- AmeriHealth to cover FluMist due to vaccine shortage.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...those individuals for whom FluMist is recommended by the Centers...has recommended the use of FluMist for healthy children and adults...exist to establish whether FluMist is safe and effective for...This article was prepared by Vaccine Weekly editors from staff and other...
- MedImmune reacquires rights to nasal flu vaccine products, including FluMist.
- Newspaper article from: Vaccine Weekly May 26, 2004 700+ words
...for the nasal flu vaccine FluMist (Influenza Virus Vaccine...marketing, and selling of FluMist. MedImmune and Wyeth believe...the commercial success of FluMist and CAIV-T, and better...This article was prepared by Vaccine Weekly editors from staff and other...
Source: HighBeam Research, FluMist maker announces plan to achieve $2 billion in revenues by...